< Back to latest news & events

Event

WIPR Patents Live webinar: Protecting medical devices in Europe—avoiding common pitfalls

July 2021

Event date: 20th July 2021

WIPR Patents Live is holding a complimentary session on July 20, at 5pm BST/12pm ET, where HGF Partner & Patent Attorney Kieran Killough will present on ‘Protecting medical devices in Europe—avoiding common pitfalls’.

Throughout the last decade, medical devices have been the subject of the most patent applications filed at the European Patent Office every year—for all but one year. This dominance reflects the year-on-year increase in investment poured into the medical device sector and, with the world currently focused on healthcare more than ever, this trend looks set to continue.

However, with approximately two-thirds of European medical device patent applications originating from outside Europe, most have not been drafted with the challenges of the European patent system and market in mind.

Together with a changing regulatory backdrop, medical device IP owners often find themselves falling foul of Europe-specific issues that may limit the scope of protection that may be achieved or, at the very least, increase costs and add delay.

In this session we will:

  • Review Europe-specific issues that regularly cause trouble for medical device patent applicants in Europe
  • Explore options for building resilience into patent applications that are destined for Europe, and will consider how to navigate objections when they arise
  • Provide insight into potential IP issues that may arise from the new EU medical device regulations, and what steps can be taken to reduce the risks posed.

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

T 1847/22: Procedural considerations in appeal: Re-ordering of requests and the impact on admissibility

Background This case concerned EP 3 085 344 B1, which relates to a wound pad, a self-adhesive member comprising a wound pad. The patent was opposed by two opponents. During …

Read article

Regulation of NGT plants in Europe- Polish Presidency proposes an alternative solution to the Patent ban

In the latest development on the new proposed legislation for the regulation of NGT (gene-edited) plants in the EU, the Polish Presidency have proposed an amendment which removes the proposed …

Read article

T 0295/22: EPO Technical Board of Appeal relies on “bonus effect” case law to find Amgen’s patent to orally administered apremilast lacking in inventive step

This case concerned Amgen’s European patent no. 2962690 for apremilast, a drug sold under the brand name Otezla®, licensed for the treatment of e.g., psoriasis and psoriatic arthritis.  The patent …

Read article
Event - 18th March 2025

Salzburg Seminar: Pitfalls in trade mark practice - What can be protected as a trade mark?

The registration of trade marks is a central component of trade mark protection – but which signs can actually be protected? In recent years, the national trade mark offices and …

Event details

Can the Chancellor’s so-called “Europe’s Silicon Valley” really replicate the innovative activity of its namesake?

The Chancellor of the UK, Rachel Reeves, recently unveiled plans to deliver an Oxford-Cambridge growth corridor that promises to boost the UK economy by up to £78 billion by 2035.  …

Read article

UPC’s CFI (Milan) extends deadline to file defence to infringement claim to align with parallel EPO appeal proceedings

Dainese S.p.A. v. Alpinestars S.p.A. & ors. UPC_CFI_472/2024 – Milan Local Division (Perrotti, Zana, Klein, Ashley) – 15 January 2025 The Milan Local Division granted a defendant’s request for an …

Read article